Cubist Systematic Strategies, LLC Charles River Laboratories International, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 3,500 shares of CRL stock, worth $526,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,700
5.41%
Holding current value
$526,155
Previous $683,000
22.99%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
613Shares Held
54.8MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$918 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$765 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$644 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$360 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$344 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.65B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...